ZA979329B - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
ZA979329B
ZA979329B ZA979329A ZA979329A ZA979329B ZA 979329 B ZA979329 B ZA 979329B ZA 979329 A ZA979329 A ZA 979329A ZA 979329 A ZA979329 A ZA 979329A ZA 979329 B ZA979329 B ZA 979329B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Application number
ZA979329A
Inventor
Hamish Ryder
Philip Anthony Ashworth
Michael Roe
Julie Elizabeth Brumwell
Sukhjit Hunjan
Adrian John Folkes
Jason Terry Sanderson
Susannah Williams
Levi Michael Maximen
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of ZA979329B publication Critical patent/ZA979329B/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA979329A 1996-10-18 1997-10-17 Pharmaceutical compounds ZA979329B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9602552 1996-10-18

Publications (1)

Publication Number Publication Date
ZA979329B true ZA979329B (en) 1999-04-19

Family

ID=10788338

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA979329A ZA979329B (en) 1996-10-18 1997-10-17 Pharmaceutical compounds

Country Status (3)

Country Link
CN (1) CN100354265C (en)
HU (1) HUP0001531A3 (en)
ZA (1) ZA979329B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524861B2 (en) * 2002-05-14 2009-04-28 David Frank Hayman Process for the preparation of a hydrate of an anthranilic acid derivative
DK2748157T3 (en) * 2011-08-26 2016-01-18 Bayer Ip Gmbh PROCEDURE FOR THE PREPARATION OF TETRAZOLE SUBSTITUTED ANTHRANILY ACID DIAMIDE DERIVATIVES BY USING BENZOXAZINONES WITH AMINES
CN102603630B (en) * 2012-03-12 2014-08-20 北京科技大学 O-aminobenzoic acid sulfonylation derivative as well as preparation method and application thereof
CA2911326A1 (en) * 2013-05-24 2014-11-27 The California Institute For Biomedical Research Compounds for treatment of drug resistant and persistent tuberculosis
CN104434947B (en) * 2014-11-07 2016-11-09 滨州医学院附属医院 The pharmaceutical composition of a kind of anti-cholangiocarcinoma and application thereof
CN104910069B (en) * 2014-12-15 2018-03-23 北京科技大学 Anthranilic acid analog derivative, its preparation method and its purposes in medicine
CN112724124A (en) * 2021-01-18 2021-04-30 林剑雄 4-hydroxyquinoline derivatives, preparation method thereof and application thereof in antitumor drugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0649410B1 (en) * 1992-07-10 1997-05-02 Laboratoires Glaxo Sa Anilide derivatives
AU5813394A (en) * 1992-12-23 1994-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellated uracil derivates
GB9426224D0 (en) * 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
CN100354265C (en) 2007-12-12
CN1241181A (en) 2000-01-12
HUP0001531A2 (en) 2000-08-28
HUP0001531A3 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
GB9602080D0 (en) Pharmaceutical compounds
GB9502874D0 (en) Pharmaceutical compounds
GB9423542D0 (en) Pharmaceutical compounds
GB9700504D0 (en) Pharmaceutical compounds
GB9410387D0 (en) Pharmaceutical compounds
GB9502861D0 (en) Pharmaceutical compounds
GB2286394B (en) Pharmaceutical compounds
GB9426224D0 (en) Pharmaceutical compounds
GB9609976D0 (en) Pharmaceutical compounds
EP1003495A4 (en) Pharmaceutical compounds
GB9716244D0 (en) Pharmaceutical compounds
GB9418326D0 (en) Pharmaceutical compounds
GB9621789D0 (en) Pharmaceutical compounds
GB9417102D0 (en) Pharmaceutical compounds
EP0923564A4 (en) Pharmaceutical compounds
ZA979329B (en) Pharmaceutical compounds
ZA98300B (en) Pharmaceutical compounds
GB9426071D0 (en) Pharmaceutical compounds
GB9626151D0 (en) Pharmaceutical compounds
GB9426080D0 (en) Pharmaceutical compounds
GB9402805D0 (en) Pharmaceutical compounds
GB9621365D0 (en) Pharmaceutical compounds
GB9613997D0 (en) Pharmaceutical compounds
GB9609299D0 (en) Pharmaceutical compounds
ZA971668B (en) Pharmaceutical compounds